share_log

Exicure | 4: Statement of changes in beneficial ownership of securities-10% Owner DGP Co., Ltd.

Exicure | 4: Statement of changes in beneficial ownership of securities-10% Owner DGP Co., Ltd.

Exicure | 4:持股变动声明-股东 DGP Co., Ltd.
美股SEC公告 ·  09/16 21:42

Moomoo AI 已提取核心信息

DGP Co., Ltd. has completed a significant acquisition of Exicure, Inc. (XCUR) common stock, purchasing 237,223 shares on September 12, 2024. The transaction was carried out directly by DGP Co., Ltd. with a purchase price of $3.00 per share, resulting in a total investment of $711,669. Following this transaction, DGP Co., Ltd. now holds a total of 849,223 shares in Exicure. This move indicates a bolstering of DGP Co., Ltd.'s stake in the biotechnology firm, which specializes in gene regulatory and immunotherapeutic drugs.
DGP Co., Ltd. has completed a significant acquisition of Exicure, Inc. (XCUR) common stock, purchasing 237,223 shares on September 12, 2024. The transaction was carried out directly by DGP Co., Ltd. with a purchase price of $3.00 per share, resulting in a total investment of $711,669. Following this transaction, DGP Co., Ltd. now holds a total of 849,223 shares in Exicure. This move indicates a bolstering of DGP Co., Ltd.'s stake in the biotechnology firm, which specializes in gene regulatory and immunotherapeutic drugs.
DGP有限公司已完成对exicure公司的重要收购,以每股3.00美元的价格购买了237,223股股票,日期为2024年9月12日。本次交易由DGP有限公司直接进行,总投资额为711,669美元。此次交易后,DGP有限公司在exicure一共持有849,223股股票。此举表明DGP有限公司在生物技术公司的持股得到了加强,该公司专注于基因调控和免疫治疗药物。
DGP有限公司已完成对exicure公司的重要收购,以每股3.00美元的价格购买了237,223股股票,日期为2024年9月12日。本次交易由DGP有限公司直接进行,总投资额为711,669美元。此次交易后,DGP有限公司在exicure一共持有849,223股股票。此举表明DGP有限公司在生物技术公司的持股得到了加强,该公司专注于基因调控和免疫治疗药物。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息